['mycobacterium infections, nontuberculous']
['lai (liposomal amikacin for inhalation) 590 mg']

        Inclusion Criteria:

          1. Be continually positive for MAC on sputum culture while adhering to a multi-drug
             treatment regimen for a minimum duration of 6 months which is either ongoing or was
             completed no more than 12 months before screening

          2. Be diagnosed with MAC NTM lung infection with evidence of nodular bronchiectasis
             and/or fibrocavitary disease by chest CT

          3. Be willing to adhere to multi-drug treatment regimen during the course of the study

        Exclusion Criteria:

          1. Patients with cystic fibrosis

          2. Positive pregnancy test or lactation at screening. All women of child bearing
             potential will be tested. Women not of childbearing potential are defined as
             postmenopausal (i.e., amenorrheic for at least 1 year), or surgically or naturally
             sterile.

          3. Active pulmonary tuberculosis requiring treatment at screening

          4. History of lung transplantation

          5. Prior exposure to LAI (including clinical study).
      